Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Farrell Michael J.Chairman and CEO | ResmedRMD | Open-market sale10b5-1 plan | 06/08 | 06/09 | 4,991 sh | $193.96 | $968,054.36 | −1.1% |
Farrell Michael J.Chairman and CEO | ResmedRMD | Open-market sale10b5-1 plan | 05/07 | 05/11 | 4,991 sh | $207.82 | $1,037,229.62 | −1.1% |
Farrell Michael J.Chairman and CEO | ResmedRMD | Open-market sale10b5-1 plan | 04/07 | 04/09 | 4,991 sh | $225.50 | $1,125,470.5 | −1.1% |
ResmedRMD | Open-market sale10b5-1 plan | 04/01 | 04/03 | 1,000 sh | $224.31 | $224,310 | −1.2% | |
Farrell Peter C.Director | ResmedRMD | Open-market sale10b5-1 plan | 04/01 | 04/02 | 2,000 sh | $225.00 | $450,000 | −3.2% |
Farrell Michael J.Chairman and CEO | ResmedRMD | Open-market sale10b5-1 plan | 03/09 | 03/11 | 4,991 sh | $251.03 | $1,252,890.73 | −1.1% |
Farrell Peter C.Director | ResmedRMD | Open-market sale10b5-1 plan | 03/04 | 03/05 | 2,000 sh | $260.22 | $520,440 | −3.1% |
ResmedRMD | Open-market sale10b5-1 plan | 03/02 | 03/03 | 1,000 sh | $254.30 | $254,300 | −1.2% | |
Farrell Michael J.Chairman and CEO | ResmedRMD | Open-market sale10b5-1 plan | 02/09 | 02/10 | 4,991 sh | $273.78 | $1,366,435.98 | −1.1% |
Farrell Peter C.Director | ResmedRMD | Open-market sale10b5-1 plan | 02/04 | 02/06 | 2,000 sh | $251.31 | $502,620 | −3.0% |
Rider Michael J.Global General Counsel | ResmedRMD | Open-market sale10b5-1 plan | 02/04 | 02/06 | 50 sh | $260.00 | $13,000 | −0.5% |
ResmedRMD | Open-market sale10b5-1 plan | 02/02 | 02/03 | 1,000 sh | $257.03 | $257,030 | −1.2% | |
Farrell Peter C.Director | ResmedRMD | Open-market sale10b5-1 plan | 01/07 | 01/09 | 2,000 sh | $248.83 | $497,660 | −2.9% |
Farrell Michael J.Chairman and CEO | ResmedRMD | Open-market sale10b5-1 plan | 01/07 | 01/08 | 4,991 sh | $248.46 | $1,240,063.86 | −1.1% |
ResmedRMD | Open-market sale10b5-1 plan | 01/02 | 01/05 | 1,000 sh | $241.75 | $241,750 | −1.1% | |
Rider Michael J.Global General Counsel | ResmedRMD | Open-market sale10b5-1 plan | 01/02 | 01/05 | 50 sh | $241.75 | $12,087.5 | −0.5% |
Farrell Michael J.Chairman and CEO | ResmedRMD | Open-market sale10b5-1 plan | 25/12/08 | 25/12/09 | 4,991 sh | $251.41 | $1,254,787.31 | −1.1% |
Farrell Peter C.Director | ResmedRMD | Open-market sale10b5-1 plan | 25/12/03 | 25/12/04 | 2,000 sh | $251.47 | $502,940 | −2.8% |
ResmedRMD | Open-market sale10b5-1 plan | 25/12/01 | 25/12/02 | 1,000 sh | $244.16 | $244,160 | −1.1% | |
Rider Michael J.Global General Counsel | ResmedRMD | Open-market sale10b5-1 plan | 25/12/01 | 25/12/02 | 50 sh | $244.16 | $12,208 | −0.5% |